bosentan anhydrous has been researched along with Abnormalities, Multiple in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, JT; Grant, EK | 1 |
| Apostolopoulou, SC; Papagiannis, J; Rammos, S | 1 |
2 other study(ies) available for bosentan anhydrous and Abnormalities, Multiple
| Article | Year |
|---|---|
Use of Pulmonary Hypertension Medications in Patients with Tetralogy of Fallot with Pulmonary Atresia and Multiple Aortopulmonary Collaterals.
Topics: Abnormalities, Multiple; Adolescent; Antihypertensive Agents; Bosentan; Catheterization; Child; Child, Preschool; District of Columbia; Echocardiography; Female; Hemodynamics; Hospitals, Pediatric; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Lung; Male; Phenylpropionates; Pulmonary Artery; Pulmonary Atresia; Pyridazines; Retrospective Studies; Sildenafil Citrate; Sulfonamides; Tertiary Care Centers; Tetralogy of Fallot; Young Adult | 2016 |
Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation.
Topics: Abnormalities, Multiple; Adolescent; Bosentan; Bronchitis; Exercise Tolerance; Follow-Up Studies; Fontan Procedure; Heart Defects, Congenital; Heart Transplantation; Hemodynamics; Humans; Male; Preoperative Care; Prosthesis-Related Infections; Risk Assessment; Sulfonamides; Treatment Outcome; Waiting Lists | 2005 |